Inovio

Hepatitis C Therapeutic DNA Vaccine Delivered by Inovio Biomedical's Electroporation Technology Reduces Viral Load by Up to 99.7% : Clinical Data Presented at Annual Scientific Meeting of the American Association for the Study of Liver Diseases

Inovio Biomedical Corporation (AMEX:INO), a leader in enabling the development of DNA vaccines using electroporation-based DNA delivery, announced today that its partner, Tripep AB, reported positive additional interim results from its ongoing phase I/II clinical study of its therapeutic DNA vacc...

Therapeutic DNA Vaccine Company Inovio Biomedical Reports Second Quarter 2008 Financial Results

Inovio Biomedical Corporation (AMEX: INO) (“Inovio”) today reported financial results for the three and six months ended June 30, 2008. SAN DIEGO (Business Wire EON) August 7, 2008 -- Total revenue for the three and six months ended June 30, 2008 was $663,...

New Report Just Published: World Hepatitis C Virus And Therapeutics Market Report

...Pre-Clinical Results of PRO 206 II-55 ZymoGenetics Reveals Phase Ib Results of IL-29 II-55 Phenomix Begins Phase Ia Study of PHX1766 II-56 inovio and Tripep Release Additional Interim Results for ChronVac-C(R) II-56 InterMune Starts Clinical Study of ITMN-191 II-57 Roche and Associat...

Inovio in Medical Technology

Vical Interim Clinical Results Demonstrate Safety and Tolerability of Inovio Biomedical's Electroporation DNA Delivery Technology

SAN DIEGO--(BUSINESS WIRE)--Jun 7, 2007 - Inovio Biomedical Corporation (AMEX:INO), focused on the development of DNA vaccines for cancers and infectious diseases and a novel alternative to surgery to treat localized cancers, announced today that the company's partner, Vical Incorporated, presented...

Inovio Biomedical's DNA Delivery Technology Significantly Enhances Potency of HIV DNA Vaccine

... SAN DIEGO--(BUSINESS WIRE)--Mar 26, 2007 - inovio Biomedical Corp. (AMEX:INO), which is focused on t...tigational DNA vaccine against HIV delivered using inovio Biomedical's electroporation technology. The paper...ious diseases such as HIV and hepatitis C. About inovio Biomedical Corporation ...

Inovio Biomedical's Partners to Present New Data from Two Cancer Immunotherapy Clinical Trials

... SAN DIEGO--(BUSINESS WIRE)--May 17, 2007 - inovio Biomedical Corporation (AMEX:INO), focused on the ... vaccines. In addition, Dr. Iacob Mathiesen of inovio will present a general overview of electroporation...ine for human cytomegalovirus (CMV) delivered with inovio technology; Dr. Connie Schmaljohn of USAMRIID at F...

Inovio: DNA delivery technology shows positive human results

... inovio Biomedical’s DNA Delivery Technology Signifi...elivery Technology SAN DIEGO, May 22, 2007 -- inovio Biomedical Corp. (AMEX: INO), focused on the devel...that the compelling pre-clinical data generated by inovio and partners in large animal models can be achieve...

Inovio Biomedical's DNA Delivery Technology Shows Safety and Enhances Gene Expression & Tumor Responses in Interim Melanoma Clinical Study Results

... SAN DIEGO--(BUSINESS WIRE)--May 24, 2007 - inovio Biomedical Corporation (AMEX:INO), focused on the ... as cancers such as prostate and breast cancers. inovio is poised to deliver advanced DNA-based immunother...bute to the prevention and cure of cancer. About inovio Biomedical Corporation ...

Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with Electroporation DNA Delivery Technology and New Devices at Gene Therapy Meeting

... SAN DIEGO--(BUSINESS WIRE)--Jun 6, 2007 - inovio Biomedical Corporation (AMEX:INO), focused on the ...technology were less or not effective. Two other inovio presentations reported electroporation device inno... complex infectious diseases as well as cancers. inovio is poised to deliver advanced DNA-based immunother...

More>>

Inovio in Biological Technology

Vista Partners Updates Coverage on Inovio Biomedical Corporation (Amex: INO); $3.57 Price Target

LOS ANGELES, Aug. 6 /PRNewswire/ -- Vista Partners announced today that it has updated coverage and has issued a $3.57 price target on Inovio Biomedical Corporation (Amex: INO ). "The proposed merger of Inovio and VGX would create a comprehensive DNA company that can create and deliver therap...

Vista Partners Updates Coverage on Inovio Biomedical Corporation (Amex: INO) With $3.52 Price Target

LOS ANGELES, March 5 /PRNewswire/ -- Vista Partners announced today that it has updated coverage and has issued a $3.52 price target on Inovio Biomedical Corporation (Amex: INO ). "Inovio has compelling pre-clinical and clinical data regarding the ability of their technology to significantly ...

Bio-Matrix Scientific Group Announces New Hires to Management Team

...sue imaging, DNA vaccine design, antibody- and cell-based assay. Previously, Dr. Lin was a Senior Research Scientist, Research & Development with inovio Biomedical Corp., San Diego. He received his M.D. from Central South University Xiag-Ya School of Medicine, Changsha, China, along with a M.S. Bioc...

Inovio in Biological Dictionary

Electroporation

... electroporation systems from BTX<reg>, Eppendorf ... Microslides and Chamber for BTX® Electroporation Systems. Pipettes and Pipettors ... inovio Biomedical Corporation is a late stage biomedical company focused on building an oncology franchise based on its proprietary electroporation therapy...